Y. Hashimoto et al., Detailed characterization of neuroprotection by a rescue factor Humanin against various Alzheimer's disease-relevant insults, J NEUROSC, 21(23), 2001, pp. 9235-9245
novel factor, termed Humanin (HN), antagonizes against neurotoxicity by var
ious types of familial Alzheimer's disease (AD) genes [V642I and K595N/M596
L (NL) mutants of amyloid precursor protein (APP), M146L-presenilin (PS) 1,
and N141I-PS2] and by A beta1-43 with clear action specificity ineffective
on neurotoxicity by polyglutamine repeat Q79 or superoxide dismutase 1 mut
ants. Here we report that HN can also inhibit neurotoxicity by other AD-rel
evant insults: other familial AD genes (A617G-APP, L648P-APP, A246E-PS1, L2
86V-PS1, C410Y-PS1, and H163R-PS1), APP stimulation by anti-APP antibody, a
nd other A beta peptides (A beta1-42 and A beta 25-35). The action specific
ity was further indicated by the finding that HN could not suppress neuroto
xicity by glutamate or prion fragment. Against the AD-relevant insults, ess
ential roles of Cys 8 and Ser(14) were commonly indicated, and the domain f
rom Pro(3) to Pro(19) was responsible for the rescue action of HN, in which
seven residues turned out to be essential. We also compared the neuroprote
ctive action of S14G HN (HNG) with that of activity-dependent neurotrophic
factor, IGF-I, or basic FGF for the antagonism against various AD-relevant
insults (V642I-APP, NL-APP, M146L-PS1, N141I-PS2, and A beta1-43). Although
all of these factors could abolish neurotoxicity by A beta -43, only HNG c
ould abolish cytotoxicities by all of them. HN and HN derivative peptides m
ay provide a new insight into the study of AD pathophysiology and allow new
avenues for the development of therapeutic interventions for various forms
of AD.